LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
LLY
1,058.87
+1.65%↑
JNJ
203.92
+0.27%↑
ABBV
236.16
+2.85%↑
UNH
319.35
+2.41%↑
AZN
91.01
+2.64%↑
24h
Aktuell
Min
219.13
Max
219.62
Empfehlungen | Neutral |
|---|---|
12-Monats-Prognose | -4.41% downside |
By Acuity
100%
0%
361 / 374 Ranking in Healthcare
By Trading Central
Vertrauen
Bearish Evidence
18.88 / 19.67 Unterstützung & Widerstand
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
14. Nov. 2025, 12:31 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal -- Update
DJ
Lesen
14. Nov. 2025, 12:16 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
DJ
Lesen
14. Nov. 2025, 11:20 UTC
Cidara Shares Nearly Double Premarket on Report of Takeover by Merck
DJ
Lesen
14. Nov. 2025, 11:11 UTC
Merck Nears $9.2 Billion Deal for Cidara, FT Reports, Citing Sources
DJ
Lesen
23. Juni 2025, 12:05 UTC
Cidara Shares Soar Premarket After Positive Influenza Trial Results
DJ
Lesen
14. Nov. 2025, 16:30 UTC
Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com
DJ
Lesen
14. Nov. 2025, 13:19 UTC
This Biotech Stock Is Soaring 100%. Merck Is Buying It. -- Barrons.com
DJ
Lesen
14. Nov. 2025, 12:22 UTC
Pharma Sector Becoming Bidding Battlefield -- Market Talk
DJ
Lesen
Kursveränderung
By TipRanks
12-Monats-Prognose
Durchschnitt 209.67 USD -4.41%
Hoch 221.5 USD
Tief 173 USD
Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für CIDARA THERAPEUTICS INC – Dist angeboten haben.
By TipRanks
Neutral
8 ratings
2
Buy
6
Halten
0
Sell
Basierend auf 8 Analysten, die in den letzten 3 Monaten Aktienbewertungen für CIDARA THERAPEUTICS INC – Dist abgegeben haben.
By Trading Central
Kurzfristig
Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Strong Bearish Evidence
All events are bearish.
Langfristig
Strong Bullish Evidence
All events are bullish.
By Acuity
Nachrichtenstimmung
Sehr starke bärische Evidenz
Volatilität
Unterdurchschnittlich
Nachrichtenvolumen (RCV)
Unterdurchschnittlich
$